HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans

Shock

Volumn 32, Issue 1, 2009, Pages 17-22

  Peltz, Erik D ^a   Moore, Ernest E ^a,b   Eckels, Phillip C ^b   Damle, Sagar S ^a   Tsuruta, Yuko ^c   Johnson, Jeffrey L ^a,b   Sauaia, Angela ^d   Silliman, Christopher C ^e,f   Banerjee, Anirban ^a   Abraham, Edward ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e Bonfils Blood Center   (United States)

^f Children's Hospital Colorado   (United States)

Author keywords

Critical care; Inflammation; Injury severity; Leukoreduction; Multiple organ failure; Resuscitation; Shock; Transfusion

Indexed keywords

BIOLOGICAL MARKER; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD STORAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INJURY; INJURY SEVERITY; INTENSIVE CARE; LENGTH OF STAY; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ERYTHROCYTE TRANSFUSION; FEMALE; HMGB1 PROTEIN; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SEVERITY OF ILLNESS INDEX; SHOCK; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 67749091145     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181997173     Document Type: Article

References (32)

1. Goodwin GH, Sanders C, Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38(1):14-19, 1973.
2. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425):248-251, 1999.
3. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H: Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 81(1):49-58, 2007.
4. Sha Y, Zmijewski J, Xu Z, Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180(4):2531-2537, 2008.
5. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, et al.: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8(5):487-496, 2007.
6. van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ: Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 29(4):441-445, 2008.
7. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, et al.: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288(5):L958-L965, 2005.
8. Ombrellino M, Wang H, Ajemian MS, Talhouk A, Scher LA, Friedman SG, Tracey KJ: Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 354(9188):1446-1447, 1999.
9. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Gallowitsch-Puerta M, Yang L, Yang H, Tracey KJ, et al.: Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 12(4-6):105-114, 2006.
10. Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Furie R, et al.: High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 46(10):2598-2603, 2002.
11. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, et al.: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48(4):971-981, 2003.
12. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192(4):565-570, 2000.
13. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E: Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284(4):C870-C879, 2003.
14. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279(9):7370-7377, 2004.
15. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33(8):1347-1353, 2007.
16. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33(3):564-573, 2005.
17. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, et al.: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 293(4):R1538-R1544, 2007.
18. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201(7):1135-1143, 2005.
19. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I: High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 49(9):1535-1537, 2003.
20. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I: New high mobility group box 1 assay system. Clin Chim Acta 372(1-2):173-178, 2006.
21. American Association of Blood Banks: Technical Manual. 14th ed. Bethesda, MD: American Association of Blood Banks, 2002.
22. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM: Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54(5):898-905; discussion 905-907, 2003.
23. Moore FA, Moore EE, Sauaia A: Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132(6):620-624; discussion 624-625, 1997.
24. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA, Lezotte DC: Early predictors of postinjury multiple organ failure. Arch Surg 129(1):39-45, 1994.
25. Mostafa G, Gunter OL, Norton HJ, McElhiney BM, Bailey DF, Jacobs DG: Age, blood transfusion, and survival after trauma. Am Surg 70(4):357-363, 2004.
26. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 165(6):2950-2954, 2000.
27. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72(6):1084-1091, 2002.
28. Czura CJ, Tracey KJ: Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med 31(1 suppl):S46-S50, 2003.
29. Yang H, Wang H, Czura CJ, Tracey KJ: HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 8(6):469-472, 2002.
30. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101(1):296-301, 2004.
31. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma 38(2):185-193, 1995.
32. Heron M: Deaths: leading causes for 2004. Natl Vital Stat Rep 56(5):1-95, 2007.